Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aleafia Health Inc ALEAF

Aleafia Health Inc. is a Canada-based cannabis company. The Company offers cannabis products in Canada and destined for international markets, including Australia and Germany. The Company operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. It owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.


GREY:ALEAF - Post by User

Comment by ShakngMyHead00on Apr 28, 2021 7:19pm
36 Views
Post# 33088054

RE:RE:RE:RE:RE:EU-GMP license and 1st quarter results

RE:RE:RE:RE:RE:EU-GMP license and 1st quarter results
stocktracker101 wrote: Benic said in the last earnings call that revenues from the unifor deal will take some time. It's a long term deal and should be significant as more of the patients come online. Average sale price was $7+ for medical q4. Higher margins. From a TA stand point, I can't beleive they've been able to drive it down this low.. lol.. A good sign is that this last drop to .55 was on really low volume. Scraping the bottom of the barrel here as they are running out of sellers. I still don't get how one doesn't sell at overbought 1.20+ but sells at oversold .55 three months later. That's dumb money for you. Upcoming catalyst, EUGMP cert. We shall see.. Potential double from here IMO.
bobus99 wrote: unifor deal will probably have 0 impact this quarter on revenues until collective bargain are made in the unions locals but it will make a big impact once done unsure if you understand how big unifor is in canada and all members mostly have family coverage so 300,000 is probably 600,000 ppl insurance might love cheaper price of weed vs other medication aleafia is based on medical this is the future




<< Previous
Bullboard Posts
Next >>